A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma

References

• Menon MP, Pittaluga S, Jaffe ES. The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification. Cancer J. 2012;18(5):411–420. doi:10.1097/PPO.0b013e31826aee97
   PubMed Web of Science ®Google Scholar
• Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11(1):12–23. doi:10.1038/nrclinonc.2013.197
   PubMed Web of Science ®Google Scholar
• Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019;94(5):604–616. doi:10.1002/ajh.25460
   PubMed Web of Science ®Google Scholar
• Zheng W, Lin Q, Issah MA, Liao Z, Shen J. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma. BMC Cancer. 2021;21(1):927. doi:10.1186/s12885-021-08660-4
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/s1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Shih MF, Lue KH, Wang TF, Chu SC, Huang CH. Association between the neutrophil-to-lymphocyte ratio and infection and survival in diffuse large B cell lymphoma. In Vivo. 2023;37(2):948–954. doi:10.21873/invivo.13167
   PubMed Web of Science ®Google Scholar
• Yang Z, Yu W. Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma. Clin Exp Med. 2023;23(3):815–822. doi:10.1007/s10238-022-00867-4
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang Z, Fang Q, Jian H. Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis. Cancer Cell Int. 2019;19:245. doi:10.1186/s12935-019-0962-3
   PubMed Web of Science ®Google Scholar
• Yang J, Guo X, Hao J, Dong Y, Zhang T, Ma X. The prognostic value of blood-based biomarkers in patients with testicular diffuse large B-cell lymphoma. Front Oncol. 2019;9:1392. doi:10.3389/fonc.2019.01392
   PubMed Web of Science ®Google Scholar
• Liu B, Li B, Zhou P, et al. Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL). Clin Chim Acta. 2018;482:191–198. doi:10.1016/j.cca.2018.04.013
   PubMed Web of Science ®Google Scholar
• Huang H, Fan L, Fu D, Lin Q, Shen J. High pretreatment plasma D-dimer levels predict poor survival in patients with diffuse large B-cell lymphoma in the real world. Transl Cancer Res. 2021;10(4):1723–1731. doi:10.21037/tcr-20-2908
   PubMed Web of Science ®Google Scholar
• Gradel KO, Larsen TS, Frederiksen H, et al. Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma. Ann Med. 2022;54(1):713–722. doi:10.1080/07853890.2022.2046287
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou M, Wang X, Xu J, Chen B, Ouyang J. Pretreatment C-reactive protein was an independent prognostic factor for patients with diffuse large B-cell lymphoma treated with RCHOP. Clin Chim Acta. 2016;459:150–154. doi:10.1016/j.cca.2016.05.033
   PubMed Web of Science ®Google Scholar
• Matsukawa T, Suto K, Kanaya M, et al. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol. 2020;99(12):2859–2868. doi:10.1007/s00277-020-04262-5
   PubMed Web of Science ®Google Scholar
• Yan D, Shen Z, Zhang S, et al. Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with Diffuse Large B-Cell Lymphoma. J Cancer. 2021;12(23):7010–7017. doi:10.7150/jca.62340
   PubMed Web of Science ®Google Scholar
• Wang Z, Luo S, Zhao X. The prognostic impact of Body Mass Index in Patients with diffuse large B-cell lymphoma: a meta-analysis. Nutr Cancer. 2021;73(11–12):2336–2346. doi:10.1080/01635581.2020.1823437
   PubMed Web of Science ®Google Scholar
• Park S, Han B, Cho JW, et al. Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Nutr Cancer. 2014;66(2):225–233. doi:10.1080/01635581.2014.867065
   PubMed Web of Science ®Google Scholar
• Juliette P, Hélène L, Caroline T, et al. Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study. Ann Hematol. 2023;102(7):1811–1823. doi:10.1007/s00277-023-05200-x
   PubMed Web of Science ®Google Scholar
• Besutti G, Massaro F, Bonelli E, et al. Prognostic impact of muscle quantity and quality and fat distribution in diffuse large B-cell lymphoma patients. Front Nutr. 2021;8:620696. doi:10.3389/fnut.2021.620696
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282. doi:10.1182/blood-2003-05-1545
   PubMed Web of Science ®Google Scholar
• Hua X, Duan F, Zhai W, et al. A novel inflammatory-nutritional prognostic scoring system for patients with early-stage breast cancer. J Inflamm Res. 2022;15:381–394. doi:10.2147/jir.S338421
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen S, Wang W, Wang Y, Liang Y. Inflammatory and nutritional scoring system for predicting prognosis in patients with newly diagnosed multiple myeloma. J Inflamm Res. 2023;16:7–17. doi:10.2147/jir.S390279
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329(14):987–994. doi:10.1056/nejm199309303291402
   PubMed Web of Science ®Google Scholar
• Ruppert AS, Dixon JG, Salles G, et al. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood. 2020;135(23):2041–2048. doi:10.1182/blood.2019002729
   PubMed Web of Science ®Google Scholar
• Jelicic J, Juul-Jensen K, Bukumiric Z, et al. Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models. Blood Cancer J. 2023;13(1):157. doi:10.1038/s41408-023-00930-7
   PubMed Web of Science ®Google Scholar
• Kanemasa Y, Shimoyama T, Sasaki Y, et al. A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2016;57(10):2460–2463. doi:10.3109/10428194.2016.1143940
   PubMed Web of Science ®Google Scholar
• Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. An externally validated nomogram for predicting the overall survival of patients with diffuse large B-cell lymphoma based on clinical characteristics and systemic inflammatory markers. Technol Cancer Res Treat. 2023;22:15330338231180785. doi:10.1177/15330338231180785
   Web of Science ®Google Scholar
• Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. A novel and Validated Inflammation-Based Prognosis Score (IBPS) predicts outcomes in patients with diffuse large B-cell lymphoma. Cancer Manag Res. 2023;15:651–666. doi:10.2147/cmar.S408100
   PubMed Web of Science ®Google Scholar
• Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 2004;11(Suppl 1):S45–S55. doi:10.1038/sj.cdd.4401456
   PubMed Web of Science ®Google Scholar
• Chen H, Tan C, Wang Z, et al. Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway. Biochem Pharmacol. 2023;211:115503. doi:10.1016/j.bcp.2023.115503
   PubMed Web of Science ®Google Scholar
• Ronchetti S, Ricci E, Migliorati G, Gentili M, Riccardi C. How glucocorticoids affect the neutrophil life. Int J Mol Sci. 2018;19(12):4090.
   PubMed Web of Science ®Google Scholar
• Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128–138. doi:10.1097/EDE.0b013e3181c30fb2
   PubMed Web of Science ®Google Scholar